FilingReader Intelligence
INKON Life revenue rises 2.4%, acquires oncology hospital
August 25, 2025 at 01:35 PM UTC•By FilingReader AI
INKON Life Technology reported revenue of 842.95 million yuan, up 2.4%, and net profit of 61.83 million yuan, up 12.8%, for the first half of 2025.
Growth was driven by a 25.1% increase in oncology revenue, boosted by the acquisition of a 51% stake in Changsha Kexin Oncology Hospital for 357 million yuan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
2025 semi-annual report summaryAugust 24, 2025 at 08:00 AM UTC
Summary table of non-operating fund appropriations and other related party fund transactions for January-June 2025August 24, 2025 at 08:00 AM UTC
Special report on the deposit and use of raised funds for the first half of 2025August 24, 2025 at 08:00 AM UTC
News Alerts
Get instant email alerts when INKON Life Technology publishes news
Free account required • Unsubscribe anytime